Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

Comparing the Effects of a Herbal Drug based on Echium Amoenum With Fluvoxamine in the Treatment of Adolescents with Obsessive-compulsive Disorder

Author(s): Mohamad Reza Noras, Atefeh Soltanifar, Roshanak Salari, Lida Jarahi and Maryam Hosseini Abrishami*

Volume 19, Issue 5, 2022

Published on: 17 August, 2022

Article ID: e240622206368 Pages: 7

DOI: 10.2174/1570163819666220624093416

Price: $65

Abstract

Background: Obsessive-compulsive disorder (OCD) is a severe and debilitating neuropsychiatric condition. Although selective serotonin reuptake inhibitors, tricyclic antidepressants, and cognitive- behavioral therapy are the first-line medication and treatment for OCD, an estimated 30% of patients are treatment-resistant, and complete functional recovery is rare. Natural products as adjuvant or alternative therapies should be examined to find safer and more effective ways to manage OCD.

Objectives: To investigate the potential benefits of a combined herbal drug based on Echium amoenum in treating OCD.

Methods: Design and Setting: In the psychiatric clinics of Mashhad University of Medical Sciences, 40 patients who met the criteria for the obsessive-compulsive disorder based on DSM-5 were studied in a parallel, double-blind, randomized clinical trial.

Intervention: Subjects were randomly assigned to receive Echium amoenum-Melissa officinalis syrup and fluvoxamine or placebo syrup and fluvoxamine for 8 weeks.

Outcome Measures: The efficacy of treatment and recurrence of disease were surveyed and compared according to the Yale-Brown Obsessive Compulsive Scale at weeks 0, 4, and 8.

Results: Evaluation at the 4th and 8th week showed no significant differences between the two groups (p-value = 0.11, p-value = 0.445, respectively). At the 8th week of treatment, patients in the intervention group showed a remarkable reduction in scores on the Yale-Brown Obsessive-Compulsive Scale questionnaire (p- value= 0.003), and patients in the control group didn’t ((p- value= 0.180). This study showed that the E.amoneum-M.officinalis syrup was not significantly more efficacious than the fluvoxamine tablet, but the intervention group showed a significant improving trend (p-value= 0.001).

Conclusion: While monotherapy is usually the gold standard methodology, combination or augmentation therapy may also be of merit. Consequently, studies with larger sample sizes and the inclusion of para-clinical assessments such as serologic tests can further shed light on the mechanism of action of the E. amoneum- M. officinalis syrup and deepen our understanding of its effects.

Keywords: Obsessive-compulsive disorder, OCD, adolescent, fluvoxamine, echium amoenum, melissa officinalis, persian medicine.

Graphical Abstract

[1]
Zamanian-Azodi M, Rezaei-Tavirani M, Kermani-Ranjbar T, et al. Pathophysiology, genetics, types, and treatments in obsessive compulsive disorder. Koomesh 2015; 475-87.
[2]
Stein DJ, Costa DLC, Lochner C, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers 2019; 5(1): 52.
[http://dx.doi.org/10.1038/s41572-019-0102-3] [PMID: 31371720]
[3]
Nazeer A, Latif F, Mondal A, Azeem MW, Greydanus DE. Obsessive-compulsive disorder in children and adolescents: Epidemiology, diagnosis and management. Transl Pediatr 2020; 9(Suppl. 1): S76-93.
[http://dx.doi.org/10.21037/tp.2019.10.02] [PMID: 32206586]
[4]
Sadock BJ, Sadock VA, Ruiz P. Synopsis of psychiatry: Behavioral sciences, clinical psychiatry. Wolters Kluwer 2015.
[5]
Shams G, Karam Ghadiri N, Esmaeli Tarkanboori Y, Amini H. Prevalence of obsessive-compulsive symptoms and its comorbidity with psychiatric symptoms in adolescents. Adv Cogn Sci 2008; 936: 50-9.
[6]
Alaghband-Rad J, Hakimshooshtary M. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry 2009; 18(3): 131-5.
[http://dx.doi.org/10.1007/s00787-007-0634-z] [PMID: 19190958]
[7]
(a) A WH. Child and adolescent clinical psychopharmacology. 4th ed.; (b) Sepehrmanesh ZAA, Moravveji SA, Ghoreishi FS. Comparing the effects of fluoxetine and fluvoxamine in the treatment of children and adolescents with depression. Feyz, Journal of Kashan University of Medical Sciences 2014; 18(3): 211-9.
[8]
(a) Melzer J, Deter H-C, Uehleke B. CAM in Psychiatry. Hindawi 2013.
[http://dx.doi.org/10.1155/2013/293248] ; (b) Wahlström M, Sihvo S, Haukkala A, Kiviruusu O, Pirkola S, Isometsä E. Use of mental health services and complementary and alternative medicine in persons with common mental disorders. Acta Psychiatr Scand 2008; 118(1): 73-80.
[http://dx.doi.org/10.1111/j.1600-0447.2008.01192.x] [PMID: 18595177]
[9]
Ayati Z, Sarris J, Chang D, Emami SA, Rahimi R. Herbal medicines and phytochemicals for obsessive-compulsive disorder. Phytother Res 2020; 34(8): 1889-901.
[http://dx.doi.org/10.1002/ptr.6656] [PMID: 32124509]
[10]
(a) Sayyah M, Sayyah M, Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30(1): 166-9.
[http://dx.doi.org/10.1016/j.pnpbp.2005.10.005] [PMID: 16309809] ; (b) Anushiravani M, Manteghi AA, Taghipur A, Eslami M. Comparing effectiveness of a combined herbal drug based on echium amoenum with citalopram in the treatment of major depressive disorder. Curr Drug Discov Technol 2019; 16(2): 232-8.
[http://dx.doi.org/10.2174/1570163815666180219115844] [PMID: 29468978] ; (c) Heidari M, Soltanpour A, Naseri M, Kazemnezhad A. The effect of Lemon Balm (Melissa Officinalis) on depression in patients after coronary artery bypass graft. Iran J Cardiovasc Nurs 2015; 4(2): 36-43.
[11]
(a) Faryadian S, Sydmohammadi A, Khosravi A, Kashiri M, Faryadayn P, Abasi N. Aqueous extract of Echlum amoenum elevate CSF serotonin and dopamine level in depression rat. Biomed Pharmacol J 2014; 7(1): 137-42.
[http://dx.doi.org/10.13005/bpj/463] ; (b) Lin S-H, Chou M-L, Chen W-C, et al. A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. J Ethnopharmacol 2015; 175: 266-72.
[http://dx.doi.org/10.1016/j.jep.2015.09.018] [PMID: 26408043]
[12]
(a) SoltaniFar A. Abdollahian E, Nasiraei A. Comparison of the effect of fluoxetine and clomipramine in children and adolescents with obsessive-compulsive disorder. Med J Mashhad Univ Med Sci 2007; 50: 315-20.; (b) Sayyah M, Boostani H, Pakseresht S, Malaieri A. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(8): 1513-6.
[http://dx.doi.org/10.1016/j.pnpbp.2009.08.021] [PMID: 19737592]
[13]
Soh NL, Walter G. Complementary medicine for psychiatric disorders in children and adolescents. Curr Opin Psychiatry 2008; 21(4): 350-5.
[http://dx.doi.org/10.1097/YCO.0b013e328303672f] [PMID: 18520739]
[14]
Sarris J. Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytother Res 2018; 32(7): 1147-62.
[http://dx.doi.org/10.1002/ptr.6055] [PMID: 29575228]
[15]
Raeis-Abdollahi E, Mokaberinejad R. Echium amoenum from viewpoint of Avicenna: A brief review. J Contemp Med Sci 2018; 4(4): 187-90.
[16]
Ranjbar A, Khorami S, Safarabadi M, et al. Antioxidant activity of Iranian Echium amoenum Fisch & CA Mey flower decoction in humans: A cross-sectional before/after clinical trial. Evid Based Complement Alternat Med 2006; 3(4): 469-73.
[http://dx.doi.org/10.1093/ecam/nel031] [PMID: 17173110]
[17]
Sayyah M, Siahpoosh A, Khalili H, Malayeri A, Samaee H. A double-blind, placebo-controlled study of the aqueous extract of Echium amoenum for patients with general anxiety disorder. Iran J Pharm Res 2012; 11(2): 697-701.
[PMID: 24250495]
[18]
Miraj S, Kiani S. A review study of therapeutic effects of Iranian borage (Echium amoenum Fisch). Pharm Lett 2016; 8(6): 102-9.
[19]
(a) Heidari MR, Azad EM, Mehrabani M. Evaluation of the analgesic effect of Echium amoenum Fisch & C.A. Mey. extract in mice: Possible mechanism involved. J Ethnopharmacol 2006; 103(3): 345-9.
[http://dx.doi.org/10.1016/j.jep.2005.08.027] [PMID: 16185831] ; (b) Mehrabani M, Ghassemi N, Ghannadi ESA, Shams-Ardakani M. Main phenolic compound of petals of Echium amoenum Fisch. and CA Mey., a famous medicinal plant of Iran. Daru 2005; 13(2): 65-9.
[20]
(a) Florentz C, Sohm B, Tryoen-Tóth P, Pütz J, Sissler M. Human mitochondrial tRNAs in health and disease. Cell Mol Life Sci 2003; 60(7): 1356-75.
[http://dx.doi.org/10.1007/s00018-003-2343-1] [PMID: 12943225] ; (b) Behnammanesh G, Khalilpour S, Majid A S A, Majid A M S A. Pharmacological actions and potential neuroprotective effects of Rhus coriaria L. And Echium amoenum L.: A brief review. 2015.
[21]
Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2016; 188: 204-28.
[http://dx.doi.org/10.1016/j.jep.2016.05.010] [PMID: 27167460]
[22]
(a) Jastrzębska-Stojko Z, Stojko R, Rzepecka-Stojko A, Kabała-Dzik A, Stojko J. Biological activity of propolis-honey balm in the treatment of experimentally-evoked burn wounds. Molecules 2013; 18(11): 14397-413.
[http://dx.doi.org/10.3390/molecules181114397] [PMID: 24284491] ; (b) Weitzel C, Petersen M. Cloning and characterisation of rosmarinic acid synthase from Melissa officinalis L. Phytochemistry 2011; 72(7): 572-8.
[http://dx.doi.org/10.1016/j.phytochem.2011.01.039] [PMID: 21354582]
[23]
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 2013; 10(5): 210-29.
[http://dx.doi.org/10.4314/ajtcam.v10i5.2] [PMID: 24311829]
[24]
Miraj S, Azizi N, Kiani S. A review of chemical components and pharmacological effects of Melissa officinalis L. Pharm Lett 2016; 8(6): 229-37.
[25]
Taiwo AE, Leite FB, Lucena GM, et al. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender. Indian J Pharmacol 2012; 44(2): 189-92.
[http://dx.doi.org/10.4103/0253-7613.93846] [PMID: 22529473]
[26]
Talaei A, Forouzanfar F, Akhondzadeh S. Medicinal plants in the treatment of obsessive-compulsive disorder: A review. Curr Drug Discov Technol 2021; 18(1): 8-16.
[PMID: 31660838]

Rights & Permissions Print Cite
Article Metrics
33
1
© 2024 Bentham Science Publishers | Privacy Policy